Q3 2023 Holdings
Filed 2023-11-14 | 7 holdings | $186.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $69.9M | 4,425,784 | 37.5% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $44.4M | 4,951,303 | 23.8% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $30.0M | 2,738,785 | 16.1% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $27.1M | 2,242,636 | 14.5% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $9.2M | 4,284,172 | 4.9% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $4.9M | 6,287,101 | 2.6% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $1.3M | 313,136 | 0.7% |